COAGULATION FACTOR IX RECOMBINANT HUMAN\ISOPROPYL ALCOHOL: 1,617 Adverse Event Reports & Safety Profile
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
1,617
Total FAERS Reports
65 (4.0%)
Deaths Reported
293
Hospitalizations
1,617
As Primary/Secondary Suspect
30
Life-Threatening
6
Disabilities
First Report: 20000101 · Latest Report: 20250901
What Are the Most Common COAGULATION FACTOR IX RECOMBINANT HUMAN\ISOPROPYL ALCOHOL Side Effects?
#1 Most Reported
Haemorrhage
648 reports (40.1%)
#2 Most Reported
Haemarthrosis
190 reports (11.8%)
#3 Most Reported
Fall
91 reports (5.6%)
All COAGULATION FACTOR IX RECOMBINANT HUMAN\ISOPROPYL ALCOHOL Side Effects by Frequency
| Side Effect | Reports | % of Total | Deaths | Hosp. |
|---|---|---|---|---|
| Haemorrhage | 648 | 40.1% | 3 | 76 |
| Haemarthrosis | 190 | 11.8% | 0 | 31 |
| Fall | 91 | 5.6% | 0 | 22 |
| Injury | 84 | 5.2% | 1 | 14 |
| Arthralgia | 74 | 4.6% | 0 | 21 |
| Drug ineffective | 60 | 3.7% | 0 | 6 |
| Contusion | 53 | 3.3% | 0 | 3 |
| Joint injury | 49 | 3.0% | 0 | 8 |
| Joint swelling | 48 | 3.0% | 0 | 14 |
| Limb injury | 45 | 2.8% | 1 | 7 |
| Muscle haemorrhage | 45 | 2.8% | 0 | 15 |
| Haematoma | 41 | 2.5% | 0 | 10 |
| Off label use | 40 | 2.5% | 0 | 10 |
| Pain | 37 | 2.3% | 0 | 9 |
| Head injury | 35 | 2.2% | 0 | 7 |
| Epistaxis | 34 | 2.1% | 0 | 7 |
| Death | 33 | 2.0% | 33 | 3 |
| Ligament sprain | 33 | 2.0% | 0 | 4 |
| Pain in extremity | 28 | 1.7% | 0 | 6 |
| Tooth disorder | 23 | 1.4% | 0 | 2 |
Who Reports COAGULATION FACTOR IX RECOMBINANT HUMAN\ISOPROPYL ALCOHOL Side Effects? Age & Gender Data
Gender: 3.7% female, 96.3% male. Average age: 29.4 years. Most reports from: US. View detailed demographics →
Is COAGULATION FACTOR IX RECOMBINANT HUMAN\ISOPROPYL ALCOHOL Getting Safer? Reports by Year
| Year | Reports | Deaths | Hosp. |
|---|---|---|---|
| 2000 | 1 | 0 | 0 |
| 2003 | 1 | 0 | 0 |
| 2004 | 2 | 0 | 0 |
| 2005 | 2 | 0 | 0 |
| 2007 | 2 | 0 | 1 |
| 2008 | 1 | 0 | 1 |
| 2010 | 2 | 0 | 1 |
| 2011 | 7 | 0 | 1 |
| 2012 | 6 | 0 | 0 |
| 2013 | 9 | 1 | 4 |
| 2014 | 40 | 2 | 15 |
| 2015 | 54 | 3 | 16 |
| 2016 | 64 | 4 | 19 |
| 2017 | 69 | 4 | 21 |
| 2018 | 50 | 3 | 20 |
| 2019 | 45 | 0 | 10 |
| 2020 | 24 | 3 | 7 |
| 2021 | 23 | 2 | 10 |
| 2022 | 32 | 2 | 5 |
| 2023 | 57 | 2 | 20 |
| 2024 | 48 | 0 | 21 |
| 2025 | 30 | 3 | 5 |
What Is COAGULATION FACTOR IX RECOMBINANT HUMAN\ISOPROPYL ALCOHOL Used For?
| Indication | Reports |
|---|---|
| Factor ix deficiency | 559 |
| Haemorrhage | 273 |
| Haemophilia | 75 |
| Prophylaxis | 51 |
| Haemorrhage prophylaxis | 19 |
| Haemarthrosis | 11 |
| Immune tolerance induction | 9 |
| Haemostasis | 6 |
| Injury | 6 |
COAGULATION FACTOR IX RECOMBINANT HUMAN\ISOPROPYL ALCOHOL vs Alternatives: Which Is Safer?
COAGULATION FACTOR IX RECOMBINANT HUMAN\ISOPROPYL ALCOHOL vs COAGULATION FACTOR VIIA RECOMBINANT HUMAN
COAGULATION FACTOR IX RECOMBINANT HUMAN\ISOPROPYL ALCOHOL vs COBAMAMIDE
COAGULATION FACTOR IX RECOMBINANT HUMAN\ISOPROPYL ALCOHOL vs COBICISTAT
COAGULATION FACTOR IX RECOMBINANT HUMAN\ISOPROPYL ALCOHOL vs COBICISTAT\DARUNAVIR ETHANOLATE
COAGULATION FACTOR IX RECOMBINANT HUMAN\ISOPROPYL ALCOHOL vs COBICISTAT\DARUNAVIR\EMTRICITABINE\TENOFOVIR ALAFENAMIDE
COAGULATION FACTOR IX RECOMBINANT HUMAN\ISOPROPYL ALCOHOL vs COBICISTAT\ELVITEGRAVIR\EMTRICITABINE\TENOFOVIR
COAGULATION FACTOR IX RECOMBINANT HUMAN\ISOPROPYL ALCOHOL vs COBICISTAT\ELVITEGRAVIR\EMTRICITABINE\TENOFOVIR ALAFENAMIDE
COAGULATION FACTOR IX RECOMBINANT HUMAN\ISOPROPYL ALCOHOL vs COBICISTAT\ELVITEGRAVIR\EMTRICITABINE\TENOFOVIR DISOPROXIL
COAGULATION FACTOR IX RECOMBINANT HUMAN\ISOPROPYL ALCOHOL vs COBIMETINIB
COAGULATION FACTOR IX RECOMBINANT HUMAN\ISOPROPYL ALCOHOL vs COCAETHYLENE
Official FDA Label for COAGULATION FACTOR IX RECOMBINANT HUMAN\ISOPROPYL ALCOHOL
Official prescribing information from the FDA-approved drug label.